Literature DB >> 11549299

Endothelin antagonists for chronic heart failure: do they have a role?

P J Cowburn1, J G Cleland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11549299     DOI： 10.1053/euhj.2000.2557

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  4 in total

1.  Clinical trials of endothelin antagonists in heart failure: publication is good for the public health.

Authors:  N F Kelland; D J Webb
Journal:  Heart       Date:  2007-01       Impact factor: 5.994

2.  Association of oral endothelin receptor antagonists with risks of cardiovascular events and mortality: meta-analysis of randomized controlled trials.

Authors:  Yu Pan; Chun Hu; Pei Hua Chen; Yan Hong Gu; Qing Yan Qiao; Li Hua Pan; Dong Chi Zhou; Hui Fang Gu; Shun Kun Fu; Hui Min Jin
Journal:  Eur J Clin Pharmacol       Date:  2016-12-13       Impact factor: 2.953

3.  Direct comparison of selective endothelin A and non-selective endothelin A/B receptor blockade in chronic heart failure.

Authors:  S J Leslie; J C S Spratt; S P McKee; F E Strachan; D E Newby; D B Northridge; M A Denvir; D J Webb
Journal:  Heart       Date:  2005-07       Impact factor: 5.994

4.  Cardiac toxicity of high-dose cyclophosphamide in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation.

Authors:  Samo Zver; Vesna Zadnik; Matjaz Bunc; Polona Rogel; Peter Cernelc; Mirta Kozelj
Journal:  Int J Hematol       Date:  2007-06       Impact factor: 2.490
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.